New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
16:09 EDTBLUEbluebird bio acquires Precision Genome Engineering
bluebird bio announced the acquisition of Precision Genome Engineering, or Pregenen, a privately held biotechnology company headquartered in Seattle, Washington. Pregenen is a leader in the development of gene editing and cell signaling technologies with a broad range of potential therapeutic applications. Under the terms of the agreement, bluebird bio issued the former stakeholders of Pregenen 408,667 shares of bluebird common stock at closing, and paid or assumed approximately $4.9M of current liabilities of Pregenen and its stakeholders. The former stakeholders of Pregenen are also eligible to receive up to an additional $15M in cash upon the achievement of certain preclinical milestones as well as $20.1M in cash upon achievement of certain clinical milestones and $99.9M in cash upon the achievement of certain commercial milestones with respect to product candidates identified using Pregenenís technology.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
06:33 EDTBLUEbluebird bio price target raised to $119 from $112 at Piper Jaffray
Piper Jaffray raised its price target for bluebird bio to $119 following the company's Q4 results and reiterates an Overweight rating on the name. Piper sees 2015 as a "big year" for bluebird with preliminary sickle cell data.
February 25, 2015
16:03 EDTBLUEbluebird bio reports Q4 EPS (67c), consensus (57c)
Subscribe for More Information
February 23, 2015
07:22 EDTBLUESunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
February 19, 2015
07:12 EDTBLUEWharton Health Care Club to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use